Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$824K Sell
2,275
-24
-1% -$8.22K 0.21% 77
2026
Q1
$809K Buy
2,299
+68
+3% +$24.2K 0.23% 72
2025
Q4
$730K Buy
2,231
+370
+20% +$117K 0.2% 76
2025
Q3
$525K Buy
1,861
+26
+1% +$7.54K 0.15% 96
2025
Q2
$512K Buy
1,835
+97
+6% +$27.5K 0.16% 100
2025
Q1
$541K Sell
1,738
-9
-0.5% -$2.66K 0.18% 88
2024
Q4
$455K Buy
1,747
+1
+0.1% +$297 0.15% 104
2024
Q3
$563K Hold
1,746
0.18% 93
2024
Q2
$545K Buy
1,746
+1
+0.1% +$294 0.2% 88
2024
Q1
$496K Sell
1,745
-2
-0.1% -$585 0.17% 97
2023
Q4
$503K Sell
1,747
-104
-6% -$28.3K 0.19% 100
2023
Q3
$498K Buy
1,851
+95
+5% +$23.7K 0.21% 96
2023
Q2
$390K Buy
1,756
+200
+13% +$46.4K 0.16% 107
2023
Q1
$376K Sell
1,556
-115
-7% -$28.2K 0.17% 101
2022
Q4
$439K Sell
1,671
-85
-5% -$22.8K 0.22% 91
2022
Q3
$396K Hold
1,756
0.24% 86
2022
Q2
$427K Buy
1,756
+52
+3% +$12.7K 0.25% 86
2022
Q1
$414K Buy
+1,704
New +$392K 0.23% 95

Other funds holding AMGN

Stone Summit Wealth's AMGN Position: Q2 2026 in Review

Stone Summit Wealth reduced its Amgen (AMGN) stake by 1% in Q2 2026, selling an estimated $8.22K and leaving 2,275 shares worth $824K. The position accounts for 0.21% of the portfolio, ranked #77.

Stone Summit Wealth first reported a position in AMGN in Q1 2022 and has held it in 18 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Stone Summit Wealth held 2,275 shares of Amgen worth $824K as of Q2 2026.
  • Stone Summit Wealth sold 24 Amgen shares in Q2 2026, an estimated $8.22K.
  • Amgen made up 0.21% of Stone Summit Wealth's portfolio in Q2 2026, its #77 holding.
  • Stone Summit Wealth first reported a position in Amgen in Q1 2022 and has held it in 18 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Stone Summit Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.